Status:
COMPLETED
Chemotherapy for Resectable Colorectal Liver Metastases
Lead Sponsor:
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
Collaborating Sponsors:
Marcello Di Martino
Conditions:
Metastatic Colorectal Cancer
Metastatic Liver Cancer
Eligibility:
All Genders
18+ years
Brief Summary
There is a degree of uncertainty regarding the role of perioperative chemotherapy (CTx) in the treatment of resectable colorectal liver metastases (CRLM). In the clinical practice, the combination of ...
Eligibility Criteria
Inclusion
- Patients older than 18 years with resectable liver metastases of histologically confirmed primary colorectal carcinoma.
- Minimum follow-up of five years.
Exclusion
- Patients with extrahepatic disease
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
967 Patients enrolled
Trial Details
Trial ID
NCT04513457
Start Date
January 1 2010
End Date
September 30 2020
Last Update
March 29 2021
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Reims
Reims, France
2
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, Spain
3
Hospital Clínico Universitario de Valencia
Valencia, Valencia, Spain
4
Hospital Universitario de Badajoz
Badajoz, Spain